We showed that IL-22 enhances S1PR1 expression in invasive metastatic breast cancer cells (1) and induces S1P expression and release in MSCs (2) to promote the migratory and invasive potential of breast cancer cells towards MSCs. Here, IL22 is linked to breast carcinoma.